基于生物大分子的微囊用于肠道健康:一篇综述
Minhui Xu1, Guangfu Feng1, Jun Fang1
1College of Bioscience and Biotechnology, Hunan Agricultural University, Hunan Provincial Engineering Research Center of Applied Microbial Resources Development for Livestock and Poultry, Changsha 410128, Hunan, China.
International journal of biological macromolecules
|July 19, 2024
概括
生物巨分子微囊为肠道疾病管理提供了一种新的方法. 这些先进的输送系统提高了药物的疗效,减少了副作用,改善了肠道健康.
科学领域:
- 胃肠道学和生物材料科学 科学
- 药物输送系统 药物输送系统
- 纳米技术在医学中的应用
背景情况:
- 肠道功能障碍与神经和内分泌疾病有关,这给全球健康带来了挑战.
- 传统的诊断方法是侵入性的,昂贵的,耗时的.
- 口服药物的疗效受到在到达肠道之前降解的限制.
研究的目的:
- 为肠道健康系统地审查使用生物大分子的微封装.
- 探索基于生物宏分子的微囊在减少肠道炎症中的应用和机制.
- 讨论肠道疾病的微囊输送系统的制备技术和未来潜力.
主要方法:
- 在肠道健康中基于生物宏分子的微囊应用的文献综述.
- 对微封装药物输送系统的制备技术的分析.
- 讨论通过微囊减少肠道炎症的机制.
主要成果:
- 像酸盐和酸盐这样的生物大分子在创建用于肠道药物输送的微囊方面是有效的.
- 微封装显著改善治疗效果,并最大限度地减少不良反应.
- 这些系统在向药物输送,减少炎症和疾病监测方面表现有前途.
结论:
- 使用生物大分子的微囊技术为控制肠道疾病提供了一个有前途的战略.
- 进一步研究它们的应用,机制和制备对于促进肠道健康至关重要.
- 微囊输送系统为改善肠道疾病的诊断,治疗和监测提供了潜力.
相关概念视频
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...


